Search results for “Tyrosine-kinase inhibitor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 10,266 patents, we discovered top 463 key players by total patent application. Novartis AG, Vertex Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 13.20% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 603
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 463
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 289
IRM LLC
CITY OF HAMILTON, Bermuda
Patent: 283
Array BioPharma, Inc.
Colorado, United States
Patent: 281
Bristol Myers Squibb Co.
New York, United States
Patent: 256
Scientic, Inc.
Alabama, United States
Patent: 250
Pharmacyclics LLC
California, United States
Patent: 248
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 232
Merck & Co., Inc.
New Jersey, United States
Patent: 225
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 147 patents, we discovered top 24 start-ups by total patent application. Capella Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, Shanghai KeChow Pharmaceuticals Co., Ltd. are active in this area.
STARTUP
Capella Therapeutics, Inc.
California, United States
Patent: 33
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 24
STARTUP
Shanghai KeChow Pharmaceuticals Co., Ltd.
Shanghai Shi, China
Patent: 14
STARTUP
Wellmarker Bio Co., Ltd.
South Korea
Patent: 11
STARTUP
pH Pharma Co., Ltd.
South Korea
Patent: 9
STARTUP
Ashvattha Therapeutics Inc
California, United States
Patent: 7
STARTUP
Sumitomo Dainippon Pharma Oncology, Inc.
United States
Patent: 6
STARTUP
TransThera Sciences (Nanjing), Inc.
Jiangsu Sheng, China
Patent: 5
STARTUP
HepaRegeniX GmbH
Baden-Württemberg, Germany
Patent: 5
STARTUP
Bridgene Biosciences, Inc.
California, United States
Patent: 4
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,722 patents applied in the last 5 years. We discover 446 most active companies in this area. The fast-growing The Board of Regents of The University of Texas System, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Janssen Pharmaceutica NV take 12.78% of patent filing during this period.
The Board of Regents of The University of Texas System
Texas, United States
Patent: 87
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 68
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 65
Pharmacyclics LLC
California, United States
Patent: 55
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 52
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 39
Genentech, Inc.
California, United States
Patent: 32
Loxo Oncology, Inc.
New York, United States
Patent: 31
Hanmi Pharmaceutical Co., Ltd.
South Korea
Patent: 31
Biogen MA, Inc.
Massachusetts, United States
Patent: 29
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,722 patents in last 5 years, we discover 245 new entrants. Ocular Therapeutix, Inc., Black Diamond Therapeutics, Inc., Genzyme Corp. are the most active new entrants in this area.
Ocular Therapeutix, Inc.
Massachusetts, United States
Patent: 19
Black Diamond Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Genzyme Corp.
Massachusetts, United States
Patent: 12
Henan Zhiwei Pharmaceutical Co., Ltd.
Henan Sheng, China
Patent: 11
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 10
Yaoya Technology (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 9
Nimbus Lakshmi, Inc.
Delaware, United States
Patent: 7
MSD International GmbH
Singapore
Patent: 7
Elevar Therapeutics, Inc.
Utah, United States
Patent: 7
STARTUP
Ashvattha Therapeutics Inc
California, United States
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,241 patents, we discovered top 160 universities and scientific research institutions by total patent application. The Scripps Research Institute, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Korea Institute of Science & Technology are dominant in this area. They take 23.69% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 103
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 47
Korea Institute of Science & Technology
South Korea
Patent: 40
Yale University
Connecticut, United States
Patent: 29
Emory University
Georgia, United States
Patent: 19
Regents of the University of Colorado
Colorado, United States
Patent: 14
Duquesne University of The Holy Spirit
Pennsylvania, United States
Patent: 13
Georgetown University School of Medicine
District of Columbia, United States
Patent: 13
University of Tokyo
Tokyo-to, Japan
Patent: 12
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 12
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: